Key Takeaway
You've done the research. You're ready to try a GLP-1 medication. But now the question is: who do you actually ask? Can your primary care doctor prescribe GLP-1 medications, or do you need a specialist? The short answer is yes) any licensed prescribing provider can write you a GLP-1 prescription.
You've done the research. You're ready to try a GLP-1 medication. But now the question is: who do you actually ask? Can your primary care doctor prescribe GLP-1 medications, or do you need a specialist? The short answer is yes) any licensed prescribing provider can write you a GLP-1 prescription. But the longer answer involves understanding which provider type might be the best fit for your situation.
Key Takeaways: - Yes, Your PCP Can Prescribe GLP-1 Medications - When to See a Specialist Instead - Telehealth: The Fastest Way to Get Started - Understand what to say to your doctor about glp-1 medications
Yes, Your PCP Can Prescribe GLP-1 Medications
Any licensed medical provider with prescribing authority can prescribe GLP-1 medications. That includes your primary care physician, family doctor, internist, nurse practitioner, or physician assistant. You do not need a referral to an endocrinologist or obesity medicine specialist to get started.
In fact, primary care providers write the majority of GLP-1 prescriptions in the US. These medications are well within their scope of practice for both type 2 diabetes management and weight management.
Here's what your PCP will typically do:
- Evaluate your medical history and current health conditions
- Check your BMI and assess whether you meet prescribing criteria
- Order baseline lab work including A1C, metabolic panel, and possibly thyroid function
- Discuss your weight loss goals and previous attempts
- Choose the right medication and starting dose based on your needs
- Submit prior authorization if your insurance requires it
Many PCPs are comfortable managing GLP-1 therapy from start to finish, including dose titration and side effect management. If you already have a good relationship with your PCP, this is often the simplest path forward.
"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.", Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023
Not sure if you qualify? to find out in about two minutes.
See if you qualify for GLP-1 treatment (.
When to See a Specialist Instead
While your PCP can prescribe GLP-1 medications, there are situations where a specialist might be a better choice.
Consider seeing an endocrinologist if:
- You have complex diabetes that's poorly controlled on multiple medications
- You have thyroid conditions that need monitoring alongside GLP-1 therapy
- Your PCP is unsure about dosing or medication interactions
- You've had unusual side effects that your PCP can't explain
Consider seeing an obesity medicine specialist if:
Patient Perspective: "I was surprised I qualified) I didn't think of myself as 'obese enough' for medication. But my BMI was 32 with high blood pressure, and my provider explained that's exactly who these medications were designed for.", Nicole F., 42, FormBlends patient (name changed for privacy)
- You've tried multiple weight loss medications without success
- You have a BMI over 40 and are considering a full treatment plan
- You're evaluating GLP-1 medications alongside or after
- You want a provider who specializes in metabolic health
The downside of specialists: Wait times. Many endocrinologists and obesity medicine specialists are booked weeks or months out. If you're ready to start now, waiting for a specialist appointment may not make sense (especially for straightforward cases.
Free Download: GLP-1 Eligibility Self-Assessment Checklist Walk into your appointment prepared. Our free checklist covers everything your provider needs to evaluate your eligibility for GLP-1 treatment. Get yours free) we'll email it to you instantly.
[Download CTA Button]
Telehealth: The Fastest Way to Get Started
If your PCP doesn't prescribe GLP-1 medications, or if you'd rather not wait for an appointment, telehealth is an increasingly popular option. Telehealth platforms like FormBlends connect you with licensed providers who specialize in GLP-1 therapy.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →Why patients choose telehealth for GLP-1 prescriptions:
- Speed. Most telehealth consultations happen within days, not weeks. Some platforms offer same-day evaluations.
- Convenience. You complete a health questionnaire and consult with a provider from home. No office visit, no waiting room, no taking time off work.
- Specialization. Telehealth providers who focus on GLP-1 medications see hundreds of patients on these medications. They know the nuances of dosing, titration, and side effect management.
- Simplified process. When you go through a platform like FormBlends, everything is coordinated (your consultation, prescription, and medication delivery all happen through one system.
- No insurance required. If your PCP's prescription requires fighting with insurance for prior authorization, telehealth platforms that prescribe compounded medications can bypass that process entirely.
FormBlends providers are licensed in your state and prescribe personalized compounded medications prepared by licensed US-based 503A pharmacies. ) transparent and straightforward.
Ready to get started? .
What to Say to Your Doctor About GLP-1 Medications
Walking into your appointment prepared makes a big difference. Here's how to bring up the conversation.
Be direct. You don't need to dance around it. Say something like: "I've been researching GLP-1 medications for weight management and I'd like to discuss whether I'm a good candidate."
Share your history. Mention your weight loss attempts (diets, exercise programs, other medications you've tried. This history is important for both clinical decision-making and insurance authorization.
Ask specific questions:
- "Based on my health history, am I a good candidate for a GLP-1 medication?"
- "Which GLP-1 medication would you recommend for me) semaglutide or tirzepatide?"
- "What side effects should I expect, and how do we manage them?"
- "Will my insurance cover this, or should I look at other options?"
Don't be discouraged if your PCP hesitates. Some primary care providers are less familiar with GLP-1 prescribing for weight management. If your doctor says they don't prescribe these medications, ask for a referral (or explore telehealth options.
If you want to understand the differences between your medication options before your appointment, our breaks down the key differences. You can also learn about so you know what to ask about.
Frequently Asked Questions
Do I need a referral to get a GLP-1 prescription?
No. You do not need a referral from another doctor to get a GLP-1 prescription. Your primary care provider, nurse practitioner, or physician assistant can prescribe GLP-1 medications directly. Telehealth providers can also prescribe them without a referral.
Can a nurse practitioner or PA prescribe GLP-1 medications?
Yes. Nurse practitioners (NPs) and physician assistants (PAs) with prescribing authority can prescribe GLP-1 medications in all 50 states. In some states, NPs have full prescribing authority without physician oversight. Many telehealth GLP-1 consultations are conducted by NPs and PAs.
What if my doctor refuses to prescribe a GLP-1?
Some doctors may be hesitant to prescribe GLP-1 medications for weight management. This can happen if they're not familiar with the latest clinical guidelines or if they believe lifestyle changes alone should be tried first. You can ask for a referral to an obesity medicine specialist, seek a second opinion, or explore telehealth options like FormBlends where providers specialize in these medications.
How do I prepare for my first GLP-1 appointment?
Bring a list of your current medications, your weight history for the past year, documentation of any diets or exercise programs you've tried, and recent lab work if you have it. Knowing your BMI is helpful too) you can use our to check before your visit.
Is a telehealth GLP-1 prescription as legitimate as an in-person one?
Absolutely. A prescription from a licensed telehealth provider is legally identical to one from an in-person visit. Telehealth providers are licensed in your state and follow the same prescribing guidelines. The only difference is the visit format (everything else, including the medication quality and pharmacy standards, is the same.
Let's Make This Happen
The research is clear. The options are available. The only question is whether it's right for you. A FormBlends provider can help you decide) no pressure, no commitment.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3 (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4 (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
- Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
- Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.
Last updated: 2026-03-24